← Back to Clinical Trials
Recruiting NCT07446192

NCT07446192 Magnetoencephalography (MEG) Pilot Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07446192
Status Recruiting
Phase
Sponsor University of Florida
Condition Essential Tremor
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2026-02-17
Primary Completion 2027-08

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age 84 Years
Study Type INTERVENTIONAL
Interventions
MRI and fMRI scansMEGSensor-based motor assessments

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2026-02-17 with a primary completion date of 2027-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this research is to learn more about how the brain works in people with essential tremor, and how it changes after treatment with High-Intensity Focused Ultrasound (HiFU). Essential tremor is a movement disorder that causes shaking, usually in the hands, and can make everyday tasks difficult. HiFU is a treatment that uses focused sound waves to target a small area in the brain involved in tremor. In this study, the investigators aim to understand how this treatment affects the brain's networks by using safe, non-invasive tests such as brain imaging, brain wave recordings, and movement assessments.

Eligibility Criteria

Inclusion: * Age \>50 years and \<85 years * Refractory to at least 2 first line tremor medications * Skull Density Ratio (SDR) \> = 0.35 Exclusion: * MR/MEG incompatible implants and implantable devices (ex: pacemaker) * Head tremor interfering with MEG recording * Severe depression and/or anxiety * Severe cognitive impairment

Contact & Investigator

Central Contact

subeikshanan venkatesan, MBBS

✉ subeikshanan.venkatesan@neurology.ufl.edu

📞 352-273-9000

Principal Investigator

Justin Hilliard, MD

PRINCIPAL INVESTIGATOR

University of Florida

Frequently Asked Questions

Who can join the NCT07446192 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, up to 84 Years, studying Essential Tremor. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07446192 currently recruiting?

Yes, NCT07446192 is actively recruiting participants. Contact the research team at subeikshanan.venkatesan@neurology.ufl.edu for enrollment information.

Where is the NCT07446192 trial being conducted?

This trial is being conducted at Gainesville, United States.

Who is sponsoring the NCT07446192 clinical trial?

NCT07446192 is sponsored by University of Florida. The principal investigator is Justin Hilliard, MD at University of Florida. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology